Prepared for Health Canada
Supplier name: Advanis Inc.
Contract number: HT372-194392 001 CY
Contract value: $249,730.00 (including HST)
Award date: March 10, 2020
Delivery date: July 6, 2020
Registration number: POR 114-19
For more information on this report, please contact Health Canada at:
hc.cpab.por-rop.dgcap.sc@canada.ca
Ce rapport est aussi disponible en Français.
Prepared for Health Canada
Supplier name: Advanis Inc.
June 2020
This public opinion research report presents the results of an online survey conducted by Advanis Inc. on behalf of Health Canada. The research was conducted with 10,930 Canadians between April 30 th and June 22nd, 2020.
This publication may be reproduced for non-commercial purposes only. Prior written permission must be obtained from Health Canada. For more information on this report, please contact Health Canada at:
hc.cpab.por-rop.dgcap.sc@canada.ca or at:
Health Canada, CPAB
200 Eglantine Driveway, Tunney's Pasture
Jeanne Mance Building, AL 1915C
Ottawa, Ontario K1A 0K9
Catalogue number:
H21-312/2020E-PDF
International Standard Book Number (ISBN):
978-0-660-35903-8
Related publications (registration number: POR 114-19):
Catalogue number H21-312/2020F-PDF (Final report, French)
ISBN 978-0-660-35904-5
©Her Majesty the Queen in Right of Canada, as represented by the Minister of Health, 2020
Use of cannabis is common in Canada. In 2017, Health Canada's Canadian Tobacco, Alcohol and Drugs Survey (CTADS) found that 15% of respondents 15 years of age and older reported using cannabis in the past year, with males reporting use more often than females. Canadians 15 to 24 years old were significantly more likely to use cannabis in the past 12 months than those 25 years of age and older. Use is also common in students, with 18% of students in grades 7 to 12 reporting past year use in the 2018-2019 Canadian Student Tobacco, Alcohol and Drugs Survey (CSTADS). International data for cannabis from 2017 shows the United States had a lifetime prevalence rate of 45.2% (Footnote 1), while Canada had a similar prevalence rate of 46.6% (Footnote 2). Prevalence rates for past year cannabis use were highest in North America (13.8%) when compared to other regions (Oceania (10.9%); Africa (6.4%); Europe (5.4%); Asia (1.8%)) around the world (Footnote 3).
In the 2015 Speech from the Throne, the Government of Canada committed to legalizing, regulating, and restricting access to marijuana. In 2016, the Government's Task Force on Marijuana Legalization and Regulation issued a discussion paper entitled "Toward the legalization, regulation and restriction of access to marijuana" that initiated wider consultations and dialogue regarding its intention in this area. In 2017, Bill C-45, an Act respecting cannabis and to amend the Controlled Drugs and Substances Act, the Criminal Code and other Acts, was introduced in the House of Commons. Implementation of the new Cannabis Act occurred in October 2018, creating a regulated legal market for non-medical cannabis for adults in Canada.
The legalization and regulation of cannabis in Canada has also prompted a policy and scientific requirement to collect new comprehensive data on the subject of cannabis use and non-use, including indicators in the areas of health, public safety, and markets. New research on cannabis use is helping the government better evaluate the possible impacts associated with its legalization, regulation, and restriction. In May and June 2016, Health Canada conducted the Baseline Survey on Awareness, Knowledge and Behaviour Associated with Recreational Use of Marijuana (administered by Ekos Research Associates). This study examined knowledge, perceived acceptability and health risks, patterns of recreational use, and information-seeking behaviours. This study found that 58% of respondents reported cannabis use in their lifetime and 22% reported use in the past 12 months. Among those who did not report use in the past 12 months, 85% felt they were unlikely to use cannabis once it becomes legal.
The Canadian Cannabis Survey was first conducted in 2017. It examined, in more depth, patterns of use, such as the quantities of cannabis consumed and the use of cannabis for medical purposes; the cannabis market, such as sources of cannabis and pricing; and issues of public safety, such as impaired driving. The 2018 Canadian Cannabis Survey aimed to gather additional data, such as changes to willingness to publicly report cannabis use since legalization; exposure to education campaigns, public health or safety messages; respondents' usual source of cannabis products since the Cannabis Act came into effect; and relative levels of THC and CBD typically used. In 2019, Health Canada conducted the third cycle of the Canadian Cannabis Survey (CCS). It was in the field from April 4, 2019 to June 17, 2019 and collected data from approximately 12,000 people 16 years of age and older. Of the responses that were received, 3,968 responses were from people who indicated that they had used cannabis in the past 12 months for either non-medical or medical purposes. In 2020, as in previous cycles, all respondents were asked questions regarding cannabis use and non-use in Canada; patterns of use (e.g., age of initiation, frequency of use, quantities and products used); public concerns related to cannabis (including problematic use and drug-impaired driving); perception of risk and normalization; and use of cannabis for medical purposes and reasons for this use. In addition, the 2020 Canadian Cannabis Survey collected additional information on cultivation of cannabis plants in/around the home, impacts of the COVID-19 pandemic on cannabis use and relative levels of THC and CBD in each of the cannabis products used.
The 2020 Canadian Cannabis Survey aimed to gather additional information to track changes in data collected from the 2017, 2018 and 2019 surveys, more specifically patterns of use, such as the quantities used; sources and pricing; and issues of public safety, such as impaired driving.
In conducting this research, Health Canada's objective was to collect information on the following:
The total cost of this research was $249,730.00 including HST.
The approach used was a two-step recruitment process where respondents were first recruited by telephone (both landline and mobile) using a short battery of screener questions approved by Health Canada, and consistent with the previous cycles. Respondents who completed the screener questions and qualified for the survey were then sent a link to the online survey, either by email or SMS, depending on their preference. Respondents were recruited from lists of random telephone numbers (RDD) that Advanis verified were in service. The distribution of phone numbers was approximately 95 percent mobile phones and 5 percent landline numbers.
The rationale for using a higher volume of cell phone than landline numbers came from the requirement of oversampling youth aged 16 to 24 years old. From previous experience, we know that this group is very hard to reach by conventional landline for two major reasons; first, they use their parents' landline and we have difficulty reaching them; second, if they have left their parents' house, they most likely use a cell phone rather than a landline.
In total, we called 131,660 phone numbers, and 21,355 people agreed to participate in the survey. Of these calls, 12 percent were conducted in French and 88 percent were conducted in English. The response rate calculation is presented in Appendix A. It should be noted that data collection for 2020 was conducted during the COVID-19 pandemic at a time when most of the country was shut down. Although refusals were greater than in 2019, the willingness to answer the phone was higher, and as such we contacted approximately 100,000 less phone numbers in 2020 compared to 2019, achieving a response rate of 19.0%.
During the computer assisted telephone interviews (CATI) recruit, Advanis requested permission to send the survey link to respondents' mobile phones via a Short Message Service (SMS). The advantage of SMS survey invitations are that, unlike email invitations, they avoid issues with incorrect email addresses and spam filtering. If the recruited respondent did not have a smartphone, or preferred email, survey links were sent via email. Of the respondents who completed the CATI screener, 92 percent were recruited via SMS, and 8 percent were recruited by email. Of those recruited to the online survey by SMS, 50.2% completed the online survey. Among those sent an email invitation, the completion rate of the online survey was 62.7% percent.
To increase the response rate, inbound calling was allowed and directed to interviewers trained on the survey. If the potential respondent called from the phone that was initially dialled by someone in the call centre, the calling record was automatically displayed to an interviewer.
Invite reminders were sent 3 days and 6 days after the initial invitation. A third SMS/email reminder was sent to those flagged as being under 25 years of age an additional 3 days later, in an attempt to boost response rates. Once SMS/email reminders had been sent, Advanis also conducted telephone reminders at least 3 days after the last reminder to confirm the invite had been received, and to correct email addresses if necessary. During these calls (only made once), voicemail messages were left reminding the respondents that the survey was still open, and a final invitation was triggered automatically.
The average survey length for those who used cannabis in the past 12 months was 25 minutes, and it was 12 minutes on average for those who did not use cannabis in the past 12 months. We need to keep in mind that, during an online survey, the time elapsed doesn't necessarily align perfectly with survey duration since respondents may not always complete the survey all at once. As for the duration of the recruitment interviews, the average length was just over 2 minutes.
The pretest was conducted from April 30th, 2020 to May 1 st, 2020 in both English and French. During this pretest, we recruited 164 people by phone, 64 in English and 100 in French. This translated into 27 completed online surveys, 16 English and 11 French. The validation of the data was completed the morning of May 4th. This validation included respondents who had used cannabis in the past 12 months, as well as those who had not, to ensure that all questions were tested. In reviewing the pretest data, it was recalled that, in the 2019 cycle, Health Canada had requested that questions without an opt-out option be voluntary for respondents to answer. This change was implemented again prior to the full launch for consistency. The data collection period was from April 30th to June 22nd, 2020.
Advanis utilizes technology to maximize quality control in survey programming. Having developed a proprietary survey engine tool, Advanis professionals are able to design and program a survey in a browser-based environment, eliminating the need to involve a programmer who is less familiar with the survey subject matter. Below are the steps followed to ensure the quality of the survey:
The CATI recruit script was programmed on Advanis' proprietary CATI platform with no unforeseen challenges. Advanis was able to leverage its experience with the survey programming and the reminder process to achieve high quality standards.
Advanis implemented the following to ensure the highest quality data collection:
To ensure high interview quality, our interviewers are trained to use various interviewing techniques. As well as maintaining a professional attitude, our interviewers must also be convincing, read word-for-word, take notes, probe deeper on semi-open and open questions, systematically confirm the information provided and listen to the respondent.
All Advanis Web surveys are hosted internally by Advanis, and we employ a rigorous and stringent set of data collection control mechanisms to ensure the highest quality for the data collected, including:
For all of the data collected, Advanis develops rules to check the validity of the data. These rules include items such as:
Advanis staff have used the SPSS Statistics Software for over 20 years and are very proficient users of the software. All data cleaning performed on projects are outlined in syntax files with intermediate data files saved throughout the process. This ensures that the original raw data file is never overwritten, and that if an error is discovered in our code, we can quickly and easily rerun the syntax to produce a new data file. Individuals developing code incorporate internal checks in their code (e.g., crosstabs) to ensure the syntax had the desired effect. In addition, all syntax is reviewed by another team member or technical specialist for accuracy.
The target audience for this project was Canadians who are 16 years and older. This survey included both those who had used cannabis and those who had not. A "person that uses cannabis" is someone who has used cannabis in the last 12 months. The expected incidence of cannabis use in the past 12 months in the general population is 15%, according to Health Canada data.
Key sub-population variables that required quotas were:
The sample consisted of a core sample of 10,000 Canadians aged 16 and older (those who use cannabis and those who do not). In the end, we gathered 10,930 responses (9,256 in English and 1,674 in French) in order to reach all of our quotas. Table 1 presents the results for the entire data collection versus the quota for the base sample.
Region | Minimum Sample Size | Target Sample Size | Results |
---|---|---|---|
NL | 400 | 400 | 412 |
PEI | 400 | 400 | 440 |
NS | 400 | 400 | 474 |
NB | 400 | 400 | 433 |
QC | 1,900 | 1,900 | 2,124 |
ON | 2,800 | 2,900 | 3,002 |
MB | 400 | 400 | 516 |
SK | 400 | 400 | 443 |
AB | 1,100 | 1,200 | 1,385 |
BC | 1,300 | 1,400 | 1,496 |
Territories | 180 | 200 | 205 |
Total | --- | 10,000 | 10,930 |
Age | |||
16 to 19 years | 500 | 800 | 867 |
20 to 24 years | 800 | 1,000 | 1,814 |
25 years and older | 7,000 | 8,200 | 8,249 |
Sex | |||
Male | 3,800 | 5,000 | 5,287 |
Female | 3,800 | 5,000 | 5,535 |
Missing | --- | --- | 108 |
Overall, 10,930 web interviews were conducted during data collection. The weighting of the final file was based on three variables: region, age, and sex at birth. For the 108 people who were missing a response for both sex at birth and gender, no weights were attributed. This is consistent with what was done in 2019. The cases where a weight could not be attributed were excluded from national estimates but remain in the data set. The population sizes are based on the latest Statistics Canada census results published in the 2016 Census. Since the value for the 16 to 19 age category was not available (only 15 to 19 is provided), we reduced the 15 to 19 year category by 1/5 of the size to reflect the best estimate of the number of 16 to 19 year olds. See section 4.2 for guidelines on the limitation of analysis with the weights.
Key | Region | Sex | Age | Weight |
---|---|---|---|---|
1M1 | AB | Male | 16 to 19 | 1498.4242 |
1M2 | AB | Male | 20 to 24 | 1252.2430 |
1M3 | AB | Male | 25 to 29 | 2035.2597 |
1M4 | AB | Male | 30 to 34 | 3285.2941 |
1M5 | AB | Male | 35 to 39 | 2518.8525 |
1M6 | AB | Male | 40 to 44 | 2969.7917 |
1M7 | AB | Male | 45 to 49 | 1997.8676 |
1M8 | AB | Male | 50 to 54 | 3468.4146 |
1M9 | AB | Male | 55 to 59 | 2614.4340 |
1M10 | AB | Male | 60 plus | 3557.9897 |
1F1 | AB | Female | 16 to 19 | 1258.4865 |
1F2 | AB | Female | 20 to 24 | 1704.6000 |
1F3 | AB | Female | 25 to 29 | 3352.7174 |
1F4 | AB | Female | 30 to 34 | 3011.3636 |
1F5 | AB | Female | 35 to 39 | 2266.4925 |
1F6 | AB | Female | 40 to 44 | 2236.4516 |
1F7 | AB | Female | 45 to 49 | 1958.5294 |
1F8 | AB | Female | 50 to 54 | 3383.3333 |
1F9 | AB | Female | 55 to 59 | 1826.2667 |
1F10 | AB | Female | 60 plus | 2783.3577 |
2M1 | BC | Male | 16 to 19 | 1900.0000 |
2M2 | BC | Male | 20 to 24 | 1126.8321 |
2M3 | BC | Male | 25 to 29 | 2332.1538 |
2M4 | BC | Male | 30 to 34 | 3370.2174 |
2M5 | BC | Male | 35 to 39 | 2466.6379 |
2M6 | BC | Male | 40 to 44 | 2365.5000 |
2M7 | BC | Male | 45 to 49 | 2725.0000 |
2M8 | BC | Male | 50 to 54 | 3072.5893 |
2M9 | BC | Male | 55 to 59 | 2717.6190 |
2M10 | BC | Male | 60 plus | 4029.2336 |
2F1 | BC | Female | 16 to 19 | 1832.4364 |
2F2 | BC | Female | 20 to 24 | 1345.6250 |
2F3 | BC | Female | 25 to 29 | 2194.3478 |
2F4 | BC | Female | 30 to 34 | 2939.0741 |
2F5 | BC | Female | 35 to 39 | 2551.2712 |
2F6 | BC | Female | 40 to 44 | 2469.5161 |
2F7 | BC | Female | 45 to 49 | 2609.9219 |
2F8 | BC | Female | 50 to 54 | 2988.6066 |
2F9 | BC | Female | 55 to 59 | 2783.6364 |
2F10 | BC | Female | 60 plus | 4032.9221 |
3M1 | MB | Male | 16 to 19 | 3404.0000 |
3M2 | MB | Male | 20 to 24 | 1434.3548 |
3M3 | MB | Male | 25 to 29 | 1742.8000 |
3M4 | MB | Male | 30 to 34 | 2010.0000 |
3M5 | MB | Male | 35 to 39 | 2346.4706 |
3M6 | MB | Male | 40 to 44 | 2470.9375 |
3M7 | MB | Male | 45 to 49 | 1634.1667 |
3M8 | MB | Male | 50 to 54 | 2780.3125 |
3M9 | MB | Male | 55 to 59 | 1979.5455 |
3M10 | MB | Male | 60 plus | 2149.2373 |
3F1 | MB | Female | 16 to 19 | 3191.2000 |
3F2 | MB | Female | 20 to 24 | 1692.0000 |
3F3 | MB | Female | 25 to 29 | 1725.0000 |
3F4 | MB | Female | 30 to 34 | 2528.2353 |
3F5 | MB | Female | 35 to 39 | 1791.9565 |
3F6 | MB | Female | 40 to 44 | 1657.9167 |
3F7 | MB | Female | 45 to 49 | 1744.7826 |
3F8 | MB | Female | 50 to 54 | 2061.5909 |
3F9 | MB | Female | 55 to 59 | 1768.6000 |
3F10 | MB | Female | 60 plus | 2073.1944 |
4M1 | NB | Male | 16 to 19 | 1520.0000 |
4M2 | NB | Male | 20 to 24 | 851.0000 |
4M3 | NB | Male | 25 to 29 | 1096.9444 |
4M4 | NB | Male | 30 to 34 | 1549.2308 |
4M5 | NB | Male | 35 to 39 | 1349.3750 |
4M6 | NB | Male | 40 to 44 | 1383.5294 |
4M7 | NB | Male | 45 to 49 | 1199.7619 |
4M8 | NB | Male | 50 to 54 | 1655.2778 |
4M9 | NB | Male | 55 to 59 | 1510.5000 |
4M10 | NB | Male | 60 plus | 2416.6250 |
4F1 | NB | Female | 16 to 19 | 1970.0000 |
4F2 | NB | Female | 20 to 24 | 672.1667 |
4F3 | NB | Female | 25 to 29 | 1300.0000 |
4F4 | NB | Female | 30 to 34 | 1424.3333 |
4F5 | NB | Female | 35 to 39 | 816.0714 |
4F6 | NB | Female | 40 to 44 | 1185.9524 |
4F7 | NB | Female | 45 to 49 | 1087.7083 |
4F8 | NB | Female | 50 to 54 | 1250.6000 |
4F9 | NB | Female | 55 to 59 | 1087.2414 |
4F10 | NB | Female | 60 plus | 3240.5882 |
5M1 | NL | Male | 16 to 19 | 1597.7143 |
5M2 | NL | Male | 20 to 24 | 1070.7692 |
5M3 | NL | Male | 25 to 29 | 939.6667 |
5M4 | NL | Male | 30 to 34 | 1182.0833 |
5M5 | NL | Male | 35 to 39 | 1119.6154 |
5M6 | NL | Male | 40 to 44 | 930.2778 |
5M7 | NL | Male | 45 to 49 | 892.3810 |
5M8 | NL | Male | 50 to 54 | 987.1429 |
5M9 | NL | Male | 55 to 59 | 1237.3529 |
5M10 | NL | Male | 60 plus | 1652.1951 |
5F1 | NL | Female | 16 to 19 | 965.4545 |
5F2 | NL | Female | 20 to 24 | 861.5625 |
5F3 | NL | Female | 25 to 29 | 1088.4615 |
5F4 | NL | Female | 30 to 34 | 845.5556 |
5F5 | NL | Female | 35 to 39 | 770.7143 |
5F6 | NL | Female | 40 to 44 | 807.2727 |
5F7 | NL | Female | 45 to 49 | 686.8966 |
5F8 | NL | Female | 50 to 54 | 576.0526 |
5F9 | NL | Female | 55 to 59 | 787.3214 |
5F10 | NL | Female | 60 plus | 2092.0833 |
6M1 | NS | Male | 16 to 19 | 1499.4286 |
6M2 | NS | Male | 20 to 24 | 639.6591 |
6M3 | NS | Male | 25 to 29 | 1488.3333 |
6M4 | NS | Male | 30 to 34 | 3141.2500 |
6M5 | NS | Male | 35 to 39 | 2047.0833 |
6M6 | NS | Male | 40 to 44 | 1946.0714 |
6M7 | NS | Male | 45 to 49 | 2701.3636 |
6M8 | NS | Male | 50 to 54 | 2153.8235 |
6M9 | NS | Male | 55 to 59 | 1846.2500 |
6M10 | NS | Male | 60 plus | 2130.0000 |
6F1 | NS | Female | 16 to 19 | 1539.3846 |
6F2 | NS | Female | 20 to 24 | 778.0556 |
6F3 | NS | Female | 25 to 29 | 1417.6316 |
6F4 | NS | Female | 30 to 34 | 1266.6667 |
6F5 | NS | Female | 35 to 39 | 1247.7273 |
6F6 | NS | Female | 40 to 44 | 1146.3462 |
6F7 | NS | Female | 45 to 49 | 1286.8000 |
6F8 | NS | Female | 50 to 54 | 1860.0000 |
6F9 | NS | Female | 55 to 59 | 1799.0909 |
6F10 | NS | Female | 60 plus | 2679.1176 |
7M1 | ON | Male | 16 to 19 | 2506.6466 |
7M2 | ON | Male | 20 to 24 | 1515.9603 |
7M3 | ON | Male | 25 to 29 | 2889.7020 |
7M4 | ON | Male | 30 to 34 | 4836.7816 |
7M5 | ON | Male | 35 to 39 | 4111.1735 |
7M6 | ON | Male | 40 to 44 | 4451.7553 |
7M7 | ON | Male | 45 to 49 | 3406.8045 |
7M8 | ON | Male | 50 to 54 | 4536.5789 |
7M9 | ON | Male | 55 to 59 | 3396.3380 |
7M10 | ON | Male | 60 plus | 5407.4335 |
7F1 | ON | Female | 16 to 19 | 2872.2909 |
7F2 | ON | Female | 20 to 24 | 1705.3516 |
7F3 | ON | Female | 25 to 29 | 3343.5496 |
7F4 | ON | Female | 30 to 34 | 5162.3837 |
7F5 | ON | Female | 35 to 39 | 4226.7308 |
7F6 | ON | Female | 40 to 44 | 4084.7748 |
7F7 | ON | Female | 45 to 49 | 3587.2593 |
7F8 | ON | Female | 50 to 54 | 4147.4615 |
7F9 | ON | Female | 55 to 59 | 3871.5649 |
7F10 | ON | Female | 60 plus | 6494.7481 |
8M1 | PE | Male | 16 to 19 | 506.2857 |
8M2 | PE | Male | 20 to 24 | 231.0526 |
8M3 | PE | Male | 25 to 29 | 336.8182 |
8M4 | PE | Male | 30 to 34 | 287.3077 |
8M5 | PE | Male | 35 to 39 | 242.8125 |
8M6 | PE | Male | 40 to 44 | 235.2778 |
8M7 | PE | Male | 45 to 49 | 193.7500 |
8M8 | PE | Male | 50 to 54 | 387.8571 |
8M9 | PE | Male | 55 to 59 | 361.3333 |
8M10 | PE | Male | 60 plus | 364.2857 |
8F1 | PE | Female | 16 to 19 | 337.2000 |
8F2 | PE | Female | 20 to 24 | 222.6316 |
8F3 | PE | Female | 25 to 29 | 282.1429 |
8F4 | PE | Female | 30 to 34 | 191.6667 |
8F5 | PE | Female | 35 to 39 | 204.5238 |
8F6 | PE | Female | 40 to 44 | 199.3478 |
8F7 | PE | Female | 45 to 49 | 188.8462 |
8F8 | PE | Female | 50 to 54 | 187.9032 |
8F9 | PE | Female | 55 to 59 | 173.9706 |
8F10 | PE | Female | 60 plus | 395.1923 |
9M1 | QC | Male | 16 to 19 | 1669.1048 |
9M2 | QC | Male | 20 to 24 | 953.2075 |
9M3 | QC | Male | 25 to 29 | 2138.1466 |
9M4 | QC | Male | 30 to 34 | 5128.7000 |
9M5 | QC | Male | 35 to 39 | 3520.4487 |
9M6 | QC | Male | 40 to 44 | 4165.5738 |
9M7 | QC | Male | 45 to 49 | 4133.4127 |
9M8 | QC | Male | 50 to 54 | 4612.9104 |
9M9 | QC | Male | 55 to 59 | 5067.5806 |
9M10 | QC | Male | 60 plus | 6181.2092 |
9F1 | QC | Female | 16 to 19 | 1492.0708 |
9F2 | QC | Female | 20 to 24 | 1080.8079 |
9F3 | QC | Female | 25 to 29 | 1874.0909 |
9F4 | QC | Female | 30 to 34 | 3454.2000 |
9F5 | QC | Female | 35 to 39 | 3066.0556 |
9F6 | QC | Female | 40 to 44 | 2743.6957 |
9F7 | QC | Female | 45 to 49 | 3011.8023 |
9F8 | QC | Female | 50 to 54 | 4371.3380 |
9F9 | QC | Female | 55 to 59 | 4958.2308 |
9F10 | QC | Female | 60 plus | 8000.9712 |
10M1 | SK | Male | 16 to 19 | 1849.6000 |
10M2 | SK | Male | 20 to 24 | 1288.2143 |
10M3 | SK | Male | 25 to 29 | 2067.8947 |
10M4 | SK | Male | 30 to 34 | 1838.5714 |
10M5 | SK | Male | 35 to 39 | 2995.0000 |
10M6 | SK | Male | 40 to 44 | 1477.7273 |
10M7 | SK | Male | 45 to 49 | 1444.5455 |
10M8 | SK | Male | 50 to 54 | 1959.4737 |
10M9 | SK | Male | 55 to 59 | 2239.4118 |
10M10 | SK | Male | 60 plus | 1985.7143 |
10F1 | SK | Female | 16 to 19 | 2398.5455 |
10F2 | SK | Female | 20 to 24 | 1477.8261 |
10F3 | SK | Female | 25 to 29 | 2549.0000 |
10F4 | SK | Female | 30 to 34 | 1768.8636 |
10F5 | SK | Female | 35 to 39 | 1980.5556 |
10F6 | SK | Female | 40 to 44 | 1802.2222 |
10F7 | SK | Female | 45 to 49 | 2271.0714 |
10F8 | SK | Female | 50 to 54 | 1583.9583 |
10F9 | SK | Female | 55 to 59 | 1657.8261 |
10F10 | SK | Female | 60 plus | 3027.2619 |
11M1 | Territories | Male | 16 to 19 | 400.5000 |
11M2 | Territories | Male | 20 to 24 | 525.0000 |
11M3 | Territories | Male | 25 to 29 | 512.7778 |
11M4 | Territories | Male | 30 to 34 | 557.5000 |
11M5 | Territories | Male | 35 to 39 | 364.0909 |
11M6 | Territories | Male | 40 to 44 | 276.9231 |
11M7 | Territories | Male | 45 to 49 | 268.5714 |
11M8 | Territories | Male | 50 to 54 | 661.6667 |
11M9 | Territories | Male | 55 to 59 | 467.5000 |
11M10 | Territories | Male | 60 plus | 399.4737 |
11F1 | Territories | Female | 16 to 19 | 274.9091 |
11F2 | Territories | Female | 20 to 24 | 276.4286 |
11F3 | Territories | Female | 25 to 29 | 1531.6667 |
11F4 | Territories | Female | 30 to 34 | 662.1429 |
11F5 | Territories | Female | 35 to 39 | 321.9231 |
11F6 | Territories | Female | 40 to 44 | 379.0000 |
11F7 | Territories | Female | 45 to 49 | 332.7273 |
11F8 | Territories | Female | 50 to 54 | 304.2308 |
11F9 | Territories | Female | 55 to 59 | 699.0000 |
11F10 | Territories | Female | 60 plus | 623.1818 |
Introducing weighting generates a design effect that can be attributed to weight variation. This effect increases the sampling error in comparison to the random sampling without weighting.
The following table presents the design effect (the effect of the sampling plan on the statistical power of the sample) for each region separately as well as for the entire sample. Also, this table shows the size of an "efficient" sample, which corresponds to the size of the random sample which would have the same precision degree. For the total sample, the variation of the sampling fractions comes from the fact that a certain number of interviews were completed in each region regardless of their size.
Province | Mean of weights | N | Standard deviation | Design effect | Usable sample size | Margin of error |
---|---|---|---|---|---|---|
Alberta | 2364.9701 | 1385 | 738.4031 | 1.09748453 | 1262 | 2.8% |
British Columbia | 2643.7705 | 1496 | 894.7911 | 1.11455019 | 1342 | 2.7% |
Manitoba | 2008.0118 | 516 | 401.1498 | 1.03990989 | 496 | 4.4% |
New Brunswick | 1468.4112 | 433 | 686.7054 | 1.21869838 | 355 | 5.2% |
Newfoundland and Labrador | 1072.7293 | 412 | 432.2394 | 1.16235606 | 354 | 5.2% |
Nova Scotia | 1662.1087 | 474 | 648.7712 | 1.15235764 | 411 | 4.8% |
Ontario | 3731.2802 | 3002 | 1441.3315 | 1.14921484 | 2612 | 1.9% |
Prince Edward Island | 271.1693 | 440 | 87.4271 | 1.10394671 | 399 | 4.9% |
Quebec | 3193.7098 | 2124 | 2047.6434 | 1.41107187 | 1505 | 2.5% |
Saskatchewan | 1970.8458 | 443 | 493.3510 | 1.06266235 | 417 | 4.8% |
Territories (NT, NU, YT) | 421.8218 | 205 | 189.2440 | 1.20127334 | 171 | 7.5% |
Canada | 2671.1223 | 10822 | 1602.3872 | 1.35987142 | 7958 | 1.1% |
After the data collection was completed, data cleaning was performed to ensure high quality results. As was done in the 2019 survey, questions were made voluntary (not required) instead of adding an opt-out option. This was to allow respondents to advance past any questions they did not wish to answer (with the exception of age, which was required). During data cleaning, respondents who refused to provide an answer were recoded to "Prefer not to answer".
The next step was to perform any necessary data coding. A detailed scale was used to describe quantities across the survey. Once data collection was completed, these scales were transformed into metric questions for ease of analysis. The metric question type simplifies the analysis by easily providing measures of mean, median, etc. For this recoding of scales into a metric value, the recoding used the same logic as in the 2019 Canadian Cannabis Survey, for consistency and comparability of results. The scale used was the same as in the previous phase of the project. The recode scale used for this was provided by Health Canada.
A review of open-ended responses was also performed as part of the data cleaning. Any "other" responses were recoded into existing categories when appropriate. A coding guide was created for answers that had sufficient numbers of mentions to be added in as a new response level. Specific verbatim themes that did not have a sufficient number of mentions were left in the "other" category. Based on this review, levels were added for survey questions based on the "other, please specify" responses. In Q19b, where respondents were asked about the changes in cannabis use due to COVID-19, additional levels were added after reviewing the data. In Q26a and the similar medical section question M12, a level of "orally/sublingually" was added based on a high instance of verbatim responses. For M5, similar to previous cycles, a level of "pain due to injury, illness or migraines" was added to decrease the proportion of the "other" response category.
When doing an analysis, it is important to align the analysis plan with the weighting scheme. The weights adjust the data to better reflect the population based on parameters that have been chosen to maximize the level of detail without creating distortions due to extreme weights (an extreme weight will occur when a population group is represented by a proportionally smaller subset of respondents compared to other population groups, thus introducing an important risk of bias due to their specific profile).
For this survey, the basic sociodemographic information that should be used in analysis of results are:
Using age groupings other than the ones described above for these sociodemographic categories could potentially produce distorted data. As these results would be inaccurate based on how the weights were calculated, we strongly advise not to report any results that are not aligned with these specified categories.
In the provided data file, the variable to be used to weight the data is called "weight". In this case, it was decided to project to the total population, around 28 million Canadian residents (per the 2016 Statistics Canada Census).
Any results with an unweighted cell size of less than 30 respondents should not be reported on, due to statistical robustness. The reason for suppressing results with small cell sizes is due to the increased coefficient of variation and, hence, there are larger confidence intervals around results with smaller bases.
For all estimates based on cell sizes of 30 or more, the following guidelines for data suppression related to coefficients of variation (CV) should be used when reporting results:
CV (Footnote 4) range | Estimate Stability |
0 - 16.5 | Acceptable, the estimate stable |
16.6 - 33.3 | Marginal, the estimate has moderate sampling variability and should be interpreted with caution |
>33.3 | Unacceptable, the estimate is unstable and should be suppressed |
TOTAL | % | |
GENERATED | 131660 | 100.0% |
USED | 131660 | 100.0% |
Not in service | 8249 | 6.3% |
Not residential | 1769 | 1.3% |
Line problem | 377 | 0.3% |
Fax | 355 | 0.3% |
Wrong number | 34 | 0.0% |
A. NOT VALID (Footnote 5) | 10784 | 8.2% |
VALID | 120876 | 91.8% |
Not eligible | 2846 | 2.4% |
Language barrier | 727 | 0.6% |
Age - Illness | 144 | 0.1% |
Other | 43 | 0.0% |
B. NOT SAMPLE (Footnote 6) | 3760 | 2.9% |
SAMPLE (Footnote 7) | 117116 | 89.0% |
C. Household refusal | 29449 | 25.1% |
C. Multiple household refusal | 8 | 0.0% |
D. Respondent refusal | 24154 | 20.6% |
D. Multiple respondent refusal | 47 | 0.0% |
D. FINAL refusal | 1361 | 1.2% |
D. Prolonged absence | 16 | 0.0% |
D. Incomplete | 0 | 0.0% |
C. No answer | 38108 | 32.5% |
D. Appointments | 2618 | 2.2% |
Completed interviews | 21355 | 18.2% |
% REFUSAL (Footnote 8) | 47.0% | |
% COMPLETED (Footnote 9) | 18.2% | |
ELIGIBILITY RATE (Footnote 10) | 93.4% | |
RESPONSE RATE (Footnote 11) | 19.0% |
Political neutrality certification
I hereby certify as Senior Officer of Advanis that the deliverables fully comply with the Government of Canada political neutrality requirements outlined in the Communications Policy of the Government of Canada and Procedures for Planning and Contracting Public Opinion Research.
Specifically, the deliverables do not include information on electoral voting intentions, political party preferences, standings with the electorate, or ratings of the performance of a political party or its leaders.
Signed:
Nicolas Toutant, Vice-President, Research and Evaluation
Languages: English, French
Section Introduction1
Intro1, i, ii, iii, iv, v, vi, vii, viii, viiia, x, xa, xb, xi, xii, xiii, xiiia, xiv, xv, xvi, xvii
Page Introduction
Intro1
Health Canada is conducting this research survey on knowledge about and use of cannabis. Advanis has been hired to administer the survey. Si vous préférez répondre au sondage en français, veuillez cliquer sur le bouton FRANÇAIS ci-dessus.
The survey takes between 5 and 20 minutes to complete and is voluntary and completely confidential. Your answers will remain anonymous.
If you wish to verify the authenticity of this survey please email: hc.odss-bssd.sc@canada.ca (mailto:hc.odss-bssd.sc@canada.ca)
The survey automatically moves to the next question when possible, however in some cases you need to press the right arrow button at the bottom of the screen to move to the next question. This button will not appear until you have answered the question.
To change previous answers you can press the left arrow button at the bottom of the screen. Some questions provide further information if you press the following symbol:
If you need to stop the survey at any point you can return at a later time and the survey will continue where you left off.
For help you can contact 1-888-944-9212.
©2020 Advanis Privacy Policy (http://www.advanis.ca/privacy_policy2.html)
Page Demographics
i
What is your age?
An answer is required
TREE QUESTION
ii
Is there anyone living in your home that is under the age of 18?
iii Show if ii Yes someone in household under 18
Are you the guardian and/or parent of any of the person(s) under the age of 18?
iv
What was your sex at birth?
v
What is your gender?
Refers to current gender which may be different from sex assigned at birth and may be different from what is indicated on legal documents.
vi
What is your sexual orientation? Is it:
vii
Do you live in a rural or urban area?
viii
In which province or territory do you currently live?
viiia
What type of educational institution are you currently attending?
x
Last week, did you work at a job or business?
Regardless of the number of hours
xa Show if x Did not work last week
Last week, did you have a job or business from which you were absent?
xb Show if X is Yes or xa is Yes
Does your job include any of the following hazardous or safety-sensitive tasks at least once a week?
Levels marked with * are randomized
xi
Do you identify as an Indigenous person, that is, First Nations (North American Indian, Métis or Inuk (Inuit)?
xii Show if x is not Indigenous
What ethnicity are you?
Select all that apply
xiii
Were you born in Canada?
xiiia Show if xii is No
How long have you lived in Canada?
Minimum: 0.0, Maximum: 100.0
years
Maximum is custom programmed to be respondent's age.
xiv
In general, how is your physical health?
xv
In general, how is your mental health?
xvi
What is the highest certificate, diploma or degree that you have completed?
xvii
What is your best estimate of your total household income received by all household members, from all sources, before taxes and deductions, during the year ending December 31, 2019?
Section NonMedical
MainInt, Q1, Q2, Q3, Q4a, Q4b, Q4c, Q5a, Q5b, Q5c, Q6, Q6b, Q7, Q8, Q9, Q10a, Q10b, Q11, Q12, Q13, Q14, Q15a, Q15b, Q16, Q17, Q18, Q19, Q19a, Q19b, Q20, Q21, Q22, Q23, Q24, Q25, Q26a, Q26b, Q26c, Q27, Q28, Q29a, Q29b, Q29c, Q29d, Q29e, Q29f, Q29g, Q29h, Q29i, Q30, Q31a, Q31b, Q31c, Q31d, Q31e, Q31f, Q31g, Q31h, Q31i, Q32, Q33a, Q33b, Q33c, Q33d, Q34a, Q34b, Q34c, Q35, Q35other, Q36, Q38, Q39a, Q39b, Q40, Q41, Q42a1, Q42b1, Q42a2, Q42b2, Q42a3, Q42b3, Q42a4, Q42b4, Q42a5, Q42b5, Q42a6, Q42b6, Q42a7, Q42b7, Q42a8, Q42b8, Q42a9, Q42b9, Q43, Q44, Q45, Q46, Q47, Q48a, Q48b, Q49, Q50a, Q50b, Q51, Q52, Q52b, Q52c, Q53, Q53b, Q53c, Q54, Q54b, Q55, Q55b, Q56, Q57, Q58, Q59, Q60, Q61, Q62, Q63, Q64, Q65, Q66, Q67, Q68, Q69, Q70, Q71, Q72, Q73, Q74
Page NonMedical
MainInt
In this survey when we use the term cannabis, this includes marijuana (e.g., weed, pot), hashish, hash oil or any other products made from the cannabis plant, but not synthetic cannabinoids.
When we ask about use, this includes using cannabis in its dry form or when mixed or processed into another product such as an edible, an extract, a concentrate, including hashish, a liquid, or other product.
By non-medical purposes we mean recreational (e.g., for enjoyment, pleasure, amusement), socially, for spiritual, lifestyle and other similar non-medical uses.
By medical purposes we mean used to treat a disease/disorder or to improve symptoms associated with a disease/disorder.
Q1
How socially acceptable do you think it is for a person to use the following substances occasionally?
Levels marked with * are randomized
Q2
How socially acceptable do you think it is for a person to use the following substances regularly?
Levels marked with * are randomized
Q3
How much do you think people risk harming themselves when they do each of the following activities?
Q4a
Since the new cannabis law came into effect (October 17, 2018), have you seen health warning messages on cannabis products/packages or on Health Canada's website?
Q4b Show if Q4a Yes 1 2 3 to seeing health warning messages
Have the health warning messages increased your knowledge of the harms related to cannabis use?
Q4c Show if Q4a No to seeing health Warning message
Do you feel you sufficiently know the harms related to cannabis without seeing the health warning messages?
Q5a
Since the new cannabis law came into effect (October 17, 2018), have you seen/heard education campaigns, public health or safety messages about cannabis in any of the following places?
Select all that apply
Q5b Show if Q5a Yes 1 to 14
Which of the following types of themes were the education campaigns, public health or safety messages relevant to?
Select all that apply
Q5c Show if Q5a Yes 1 to 14
Was the information you saw in the education campaigns, public health or safety messages credible/believable?
Q6
Do you agree or disagree with the following statement:
I have access to enough trustworthy information about the health risks of cannabis use to make informed decisions.
Q6b
Are you aware of the 'Lower-Risk Cannabis Use Guidelines' (LRCUG)?
Q7
Based on what you know or believe…
Q8
In the past 12 months, how have people, including yourself, used cannabis inside your home?
Select all that apply
Q9
In the past 30 days, were you exposed to second-hand cannabis smoke or vapor at the following locations?
Q10a
In the past 12 months, has anyone, including yourself, grown cannabis in or around your home/residence?
Q10b Show if Q10a Yes
How many cannabis plants are currently grown in or around your home/residence?
Minimum: 1.0, Maximum: 25.0
Enter number of plants
Q11
In the past 12 months, has anyone, including yourself, prepared cannabis edibles/drinks in your home/residence?
Q12
In your opinion, does using cannabis for non-medical purposes impair one's ability to drive or operate a motor vehicle?
Q13
As far as you know, when is it safe for someone to drive a motor vehicle after using cannabis for non-medical purposes?
Q14
How likely do you think it is that a person will be caught by police if they drive while under the influence of the following substances?
Q15a
Have you ever been a passenger in a motor vehicle (e.g., car, snowmobile, motor boat or all-terrain vehicle (ATV)) driven by someone who had used cannabis for non-medical purposes within 2 hours before driving?
Q15b Show if Q15a Yes passenger in vehicle
Q16
During your lifetime have you ever used cannabis for non-medical *?* purposes?
*?* By non-medical purposes we mean recreational (e.g., for enjoyment, pleasure, amusement), socially, for spiritual, lifestyle and other similar non-medical uses.
Q17 Show if Q16 Used nonmedical in lifetime
How old were you when you first tried or started using cannabis for non-medical purposes?
TREE QUESTION
Q18
In the past 12 months, have you used cannabis for medical purposes (used to treat disease/disorder or improve symptoms)?
Q19 Show if Q16 Used nonmedical in lifetime
In the past 12 months, have you used cannabis for non-medical purposes?
Q19a Show if Q19 NonMedical User past 12 months
How, if at all, has your cannabis use for non-medical purposes changed due to the COVID-19 pandemic? *?*
*?* novel coronavirus outbreak.
Q19b Show if Q19a use more or less
Why did your cannabis use for non-medical purposes change due to the COVID-19 pandemic? *?*
Select all that apply
*?* novel coronavirus outbreak.
Q20 Show if Q19 NonMedical User past 12 months
Are you more willing to publicly say whether you use cannabis for non-medical purposes now that the new cannabis law is in effect as of October 17, 2018?
Q21 Show if Q19 NonMedical User past 12 months
In the past 12 months, how often did you typically use cannabis for non-medical purposes?
Q22 Show if Q19 NonMedical User past 12 months
In the past 30 days, have you used cannabis for non-medical purposes?
Q23 Show if Q22 NonMedical User past 30 days
In the past 30 days, on how many days did you use cannabis for non-medical purposes?
Minimum: 1.0, Maximum: 30.0
Please enter the number of days
Q24 Show if Q22 NonMedical User past 30 days
In the past 30 days, on the days that you used cannabis for non-medical purposes, how many times (a time includes a period of continuous use) per day did you use on average?
Q25 Show if Q22 NonMedical User past 30 days
In the past 30 days, how many hours were you "stoned" or "high" on a typical day when you had been using cannabis for non-medical purposes?
Q26a Show if Q19 NonMedical User past 12 months
In the past 12 months, did you use the following method to consume cannabis for non-medical purposes?
Select all that apply
Q26b Show if Q26a Vaporized with a portable 5 or nonportable 4 device
What cannabis products did you use when vaporizing cannabis?
Select all that apply
Q26c Show if Q26a 5 Vaporized with portable device
What type of portable vaping device did you use when vaporizing cannabis?
Q27 Show if Q19 NonMedical User past 12 months
When choosing cannabis products for non-medical purposes, what levels of THC and CBD do you typically use?
Q28 Show if Q19 NonMedical User past 12 months
In the past 12 months, have you used the following cannabis products for non-medical purposes?
Select all that apply
Q29a Show if Q28 1 Used Dried flower leaf past 12 months
When choosing cannabis products for non-medical purposes, what levels of THC and CBD do you typically use for:
Dried flower/leaf ?
Please make a selection in each of the CBD and THC sections.
THC Levels
Q29b Show if Q28 2 Used Hashish kief past 12 months
When choosing cannabis products for non-medical purposes, what levels of THC and CBD do you typically use for:
Hashish/kief ?
Please make a selection in each of the CBD and THC sections.
THC Levels
Q29c Show if Q28 3 Used Cannabis oil for oral use past 12 months
When choosing cannabis products for non-medical purposes, what levels of THC and CBD do you typically use for:
Cannabis oil for oral use - e.g., in dropper/syringe, softgel/capsules, spray bottle ?
Please make a selection in each of the CBD and THC sections.
THC Levels
CBD Levels
Q29d Show if Q28 4 Used Cannabis vape pens past 12 months
When choosing cannabis products for non-medical purposes, what levels of THC and CBD do you typically use for:
Cannabis vape pens/cartridges ?
Please make a selection in each of the CBD and THC sections.
THC Levels
CBD Levels
Q29e Show if Q28 5 Used Cannabis concentrate past 12 months
When choosing cannabis products for non-medical purposes, what levels of THC and CBD do you typically use for:
Cannabis concentrate/extracts - e.g., shatter/wax/budder/butane honey oil ?
Please make a selection in each of the CBD and THC sections.
THC Levels
CBD Levels
Q29f Show if Q28 6 Used Cannabis edibles past 12 months
When choosing cannabis products for non-medical purposes, what levels of THC and CBD do you typically use for:
Cannabis edible food products - e.g., cookies, candy ?
Please make a selection in each of the CBD and THC sections.
THC Levels
CBD Levels
Q29g Show if Q28 7 Used Cannabis beverages past 12 months
When choosing cannabis products for non-medical purposes, what levels of THC and CBD do you typically use for:
Cannabis beverages - e.g., cola, tea, coffee ?
Please make a selection in each of the CBD and THC sections.
THC Levels
CBD Levels
Q29h Show if Q28 8 Used Topicals past 12 months
When choosing cannabis products for non-medical purposes, what levels of THC and CBD do you typically use for:
Topicals - e.g., lotion, ointment, creams applied to skin ?
Please make a selection in each of the CBD and THC sections.
THC Levels
CBD Levels
Q29i Show if Q28 9 Used Other past 12 months
When choosing cannabis products for non-medical purposes, what levels of THC and CBD do you typically use for:
Other: <<Q28.specify(9)>> ?
Please make a selection in each of the CBD and THC sections.
THC Levels
CBD Levels
Q30 Show if Q19 NonMedical User past 12 months
In the past 12 months, how often have you used the following cannabis products for non-medical purposes?
Q31a Show if Q28 1 Used Dried flower leaf past 12 months
On the days that you used:
Dried flower/leaf How much did you typically use in a day, for non-medical purposes?
Please select the amount closest to what you typically use
TREE QUESTION
Q31b Show if Q28 2 Used Hashish kief past 12 months
On the days that you used:
Hashish/kief How much did you typically use in a day, for non-medical purposes?
Please select the amount closest to what you typically use
TREE QUESTION
Q31c Show if Q28 3 Used Cannabis oil for oral use past 12 months
On the days that you used:
Cannabis oil for oral use - e.g., in dropper/syringe, softgel/capsules, spray bottle How much did you typically use in a day, for non-medical purposes?
Please select the amount closest to what you typically use
TREE QUESTION
Q31d Show if Q28 4 Used Cannabis vape pens past 12 months
On the days that you used:
Cannabis vape pens/cartridges How much did you typically use in a day, for non-medical purposes?
Please select the amount closest to what you typically use
Q31e Show if Q28 5 Used Cannabis concentrate past 12 months
On the days that you used:
Cannabis concentrate/extracts - e.g., shatter/wax/budder/butane honey oil How much did you typically use in a day, for non-medical purposes?
Please select the amount closest to what you typically use
Q31f Show if Q28 6 Used Cannabis edibles past 12 months
On the days that you used:
Cannabis edible food products - e.g., cookies, candy How much did you typically use in a day, for non-medical purposes?
Please select the amount closest to what you typically use
TREE QUESTION
Q31g Show if Q28 7 Used Cannabis beverages past 12 months
On the days that you used:
Cannabis beverages - e.g., cola, tea, coffee How much did you typically use in a day, for non-medical purposes?
Please select the amount closest to what you typically use
TREE QUESTION
Q31h Show if Q28 8 Used Topicals past 12 months
On the days that you used:
Topicals - e.g., lotion, ointment, creams applied to skin How much did you typically use in a day, for non-medical purposes?
Please do not enter personally-identifying information.
Q31i Show if Q28 9 Used Other past 12 months
On the days that you used:
Other: <<Q28.specify(9)>> How much did you typically use in a day, for non-medical purposes?
Please do not enter personally-identifying information.
Q32 Show if Q19 NonMedical User past 12 months
In the past 12 months from whom did youusually buy or receive the cannabis you used for non-medical purposes?
Q33a Show if Q19 NonMedical User past 12 months
In the past 12 months, how often did you buy or receive any cannabis for non-medical purposes from a legal/licensed source?
Q33b Show if Q33a 1 2 3 or 4
In the past 12 months, what were these sources?
Select all that apply
Q33c Show if Q33b 3 From someone sharing with me
Did you pay the person(s) for the cannabis they shared with you?
Q33d Show if Q33a 1 2 3 or 4
How, if at all, has your access to cannabis for non-medical purposes from legal/licensed sources changed due to the COVID-19 pandemic? *?*
Select all that apply
Q34a Show if Q19 NonMedical User past 12 months
In the past 12 months, how often did you buy or receive any cannabis for non-medical purposes from an illegal/unlicensed source?
Q34b Show if Q34a 1 2 3 or 4
In the past 12 months, what were these sources?
Select all that apply
Q34c Show if Q34a 1 2 3 or 4
How, if at all, has your access to cannabis for non-medical purposes from illegal/unlicensed sources changed due to the COVID-19 pandemic? *?*
Select all that apply
Q35 Show if Q19 NonMedical User past 12 months
Which factors most influence from whom you usually buy or receive the cannabis you use for non-medical purposes?
Please rank your top 3 choices. You may use the arrows to move a selection up or down, and the X to remove a selection.
Q35other Show if Q35 Other Selected in top 3
What is the other factor that influences from whom you usually buy or receive the cannabis you use for non-medical purposes?
Please do not enter personally-identifying information.
Q36 Show if Q19 NonMedical User past 12 months
In the past 12 months, how often have you intended to buy a cannabis product for non-medical purposes from a provincially regulated retailer but have found the product you wanted to buy was unavailable?
Q38 Show if Q19 NonMedical User past 12 months
How much do you typically spend on cannabis for non-medical purposes each month?
Minimum: 0.0, Maximum: 1000.0
Enter estimated dollar amount
Q39a Show if Q22 NonMedical User past 30 days
In the past 30 days, how much did you spend on cannabis for non-medical purposes obtained from a legal source?
Minimum: 0.0, Maximum: 1000.0
Enter estimated dollar amount
Q39b Show if Q22 NonMedical User past 30 days
In the past 30 days, how much did you spend on cannabis for non-medical purposes obtained from an illegal source?
Minimum: 0.0, Maximum: 1000.0
Enter estimated dollar amount
Q40 Show if Q22 NonMedical User past 30 days
In the past 30 days, which form(s) of cannabis have you bought or received for non-medical purposes?
Select all that apply
Q41 Show if Q22 NonMedical User past 30 days
In the past 30 days, how often have you bought or received cannabis in the following form(s) for non-medical purposes?
Q42a1 Show if Q40 1 Used Dried flower leaf past 30 days
Typically, how much cannabis in the form:
Dried flower/leaf did you buy or receive each time for non-medical purposes?
Please select the amount closest to what you typically bought or received each time.
TREE QUESTION
Q42b1 Show if Q40 1 Used Dried flower leaf past 30 days
How much did you pay for this amount?
Minimum: 0.0, Maximum: 1000.0
Enter dollar amount
Q42a2 Show if Q40 2 Used Hashish kief past 30 days
Typically, how much cannabis in the form:
Hashish/kief did you buy or receive each time for non-medical purposes?
Please select the amount closest to what you typically bought or received each time.
TREE QUESTION
Q42b2 Show if Q40 2 Used Hashish kief past 30 days
How much did you pay for this amount?
Minimum: 0.0, Maximum: 1000.0
Enter dollar amount
Q42a3 Show if Q40 3 Used Cannabis oil for oral past 30 days
Typically, how much cannabis in the form:
Cannabis oil for oral use - e.g., in dropper/syringe, softgel/capsules, spray bottle did you buy or receive each time for non-medical purposes?
Please select the amount closest to what you typically bought or received each time.
TREE QUESTION
Q42b3 Show if Q40 3 Used Cannabis oil for oral past 30 days
How much did you pay for this amount?
Minimum: 0.0, Maximum: 1000.0
Enter dollar amount
Q42a4 Show if Q40 4 Used Cannabis vape pens past 30 days
Typically, how much cannabis in the form:
Cannabis vape pens/cartridges did you buy or receive each time for non-medical purposes?
Please select the amount closest to what you typically bought or received each time.
Q42b4 Show if Q40 4 Used Cannabis vape pens past 30 days
How much did you pay for this amount?
Minimum: 0.0, Maximum: 1000.0
Enter dollar amount
Q42a5 Show if Q40 5 Used Cannabis concentrate past 30 days
Typically, how much cannabis in the form:
Cannabis concentrate/extracts - e.g., shatter/wax/budder/butane honey oil did you buy or receive each time for non-medical purposes?
Please select the amount closest to what you typically bought or received each time.
TREE QUESTION
Q42b5 Show if Q40 5 Used Cannabis concentrate past 30 days
How much did you pay for this amount?
Minimum: 0.0, Maximum: 1000.0
Enter dollar amount
Q42a6 Show if Q40 6 Used Cannabis edibles past 30 days
Typically, how much cannabis in the form:
Cannabis edible food products - e.g., cookies, candy did you buy or receive each time for non-medical purposes?
Please select the amount closest to what you typically bought or received each time.
TREE QUESTION
Q42b6 Show if Q40 6 Used Cannabis edibles past 30 days
How much did you pay for this amount?
Minimum: 0.0, Maximum: 1000.0
Enter dollar amount
Q42a7 Show if Q40 7 Used Cannabis beverage past 30 days
Typically, how much cannabis in the form:
Cannabis beverages - e.g., cola, tea, coffee did you buy or receive each time for non-medical purposes?
Please select the amount closest to what you typically bought or received each time.
TREE QUESTION
Q42b7 Show if Q40 7 Used Cannabis beverage past 30 days
How much did you pay for this amount?
Minimum: 0.0, Maximum: 1000.0
Enter dollar amount
Q42a8 Show if Q40 8 Used Topicals past 30 days
Typically, how much cannabis in the form:
Topicals - e.g., lotion, ointment, creams applied to skin did you buy or receive each time for non-medical purposes?
Please do not enter personally-identifying information.
Q42b8 Show if Q40 8 Used Topicals past 30 days
How much did you pay for this amount?
Minimum: 0.0, Maximum: 1000.0
Enter dollar amount
Q42a9 Show if Q40 9 Used Other past 30 days
Typically, how much cannabis in the form:
Other: <<Q40.specify(9)>> did you buy or receive each time for non-medical purposes?
Please do not enter personally-identifying information.
Q42b9 Show if Q40 9 Used Other past 30 days
How much did you pay for this amount?
Minimum: 0.0, Maximum: 1000.0
Enter dollar amount
Q43 Show if Q22 NonMedical User past 30 days
In the past 30 days, where have you used cannabis for non-medical purposes?
Select all that apply
Q44 Show if viiia Is Student AND Q19 NonMedical user past 12 months
In the past 12 months, how often did you use cannabis fornon-medical purposes at school/college/university or within 2 hours before going to school/college/university?
Q45 Show if viiia Is Student AND Q19 NonMedical user past 12 months
In a typical month, how often are you absent fromschool/college/university because of your non-medical use of cannabis?
Q46 Show if Q19 NonMedical User past 12 months
In the past 12 months, how often did you use cannabis for non-medical purposes at work (including breaks) or within 2 hours before going to work?
Q47 Show if Q46 NOT Havent been employed past 12 months
In a typical month, how often are you absent from work because of your non-medical use of cannabis?
Q48a Show if Q19 NonMedical User past 12 months
Do you currently have any cannabis or cannabis product in or around your home?
Q48b Show if Q48a Yes cannabis in house
Where is the cannabis that is currently in or around your home being stored?
Select all that apply
Q49 Show if Q19 NonMedical User past 12 months
During the past 12 months, when you used cannabis, how often did you combine it with any of the following substances?
"Combine" means mixed or consumed at the same time.
Q50a Show if Q19 NonMedical User past 12 months
Were there any other substances that you used in combination (i.e., at the same time) with cannabis fornon-medical purposes for the effect in the past 12 months?
Q50b Show if Q50a Yes other substance
And how often did you use <<Q50a.specify(1)>> in combination (i.e., at the same time) with cannabis for non-medical purposes for the effect?
Q51 Show if Q19 NonMedical User past 12 months
Since cannabis became legal for non-medical purposes, has your consumption of the following substances changed?
Q52 Show if Q19 NonMedical User past 12 months
Have you driven a motor vehicle (e.g., car, snowmobile, motor boat or all-terrain vehicle (ATV)) within 2 hours of smoking or vaporizing cannabis or a cannabis product for non-medical purposes?
Q52b Show if Q52 Yes driven within 2hrs of smoking vaping
When did this last happen?
Q52c Show if Q52 Yes AND Q52b within past 30 days
What type of cannabis product was it?
Q53 Show if Q19 NonMedical User past 12 months
Have you driven a motor vehicle (e.g., car, snowmobile, motor boat or all-terrain vehicle (ATV)) within 4 hours of ingesting a cannabis product (e.g., cannabis food/beverages, capsules) for non-medical purposes?
Q53b Show if Q53 Yes driven within 4hrs of ingesting
When did this last happen?
Q53c Show if Q53 Yes AND Q53b within past 30 days
What type of cannabis product was it?
Q54 Show if Q52 Yes driven 2hrs smoking vaping OR Q53 Yes driven 4hrs eating
Have you driven a motor vehicle (e.g., car, snowmobile, motor boat or all-terrain vehicle (ATV)) within 2 hours of using cannabis or a cannabis product for non-medical purposes in combination with alcohol?
Q54b Show if Q54 Yes driven within 2hrs combined with alcohol
When did this last happen?
Q55 Show if Q52 Yes driven 2hrs smoking vaping OR Q53 Yes driven 4hrs eating
Have you driven a motor vehicle (e.g., car, snowmobile, motor boat or all-terrain vehicle (ATV)) within 2 hours of using cannabis or a cannabis product for non-medical purposes in combination with another drug other than alcohol or tobacco?
Q55b Show if Q55 Yes driven within 2hrs combined with another drug
When did this last happen?
Q56 Show if Q52 Yes driven 2hrs smoking vaping OR Q53 Yes driven 4hrs eating
Why did you drive a motor vehicle after using cannabis?
Select all that apply
Q57 Show if Q18 Medical OR Q19 NonMedical users past 12 months
In the past 12 months, have you, as the driver, ever had an interaction with police/law enforcement involving driving under the influence of cannabis?
Q58 Show if Q19 NonMedical User past 12 months
In the past 12 months, did you personally have an interaction with police/law enforcement involving your personal possession of cannabis for non-medical purposes?
Q59 Show if Q19 NonMedical User past 12 months
During the past 12 months, what type of effect did your cannabis use for non-medical purposes have on your:
Levels marked with * are randomized
Q60 Show if Q19 NonMedical User past 12 months
During the past 3 months, how often did you use cannabis for non-medical purposes?
Q61 Show if Q60 Used NonMedical past 3 months
During the past 3 months, how often have you had a strong desire or urge to use cannabis for non-medical purposes?
Q62 Show if Q60 Used NonMedical past 3 months
During the past 3 months, how often has your use of cannabis for non-medical purposes led to health, social, legal or financial problems?
Q63 Show if Q60 Used NonMedical past 3 months
During the past 3 months, how often have you failed to do what was normally expected of you because of your use of cannabis for non-medical purposes?
Q64 Show if Q60 Used NonMedical past 3 months
Has a friend or relative or anyone else ever expressed concern about your use of cannabis for non-medical purposes?
Q65 Show if Q60 Used NonMedical past 3 months
Have you ever tried and failed to control, cut down or stop using cannabis for non-medical purposes?
Q66 Show if Q16 Used nonmedical more than once in lifetime
During your lifetime, did you feel that you needed professional help (such as treatment or counseling) for your non-medical use of cannabis?
Q67 Show if Q16 Used nonmedical more than once in lifetime
Have you ever received professional help (such as treatment or counseling) for your non-medical use of cannabis?
Q68 Show if Is 19 or older non ABQC OR 18 or older AB OR 21 or older QC AND 19 NonMedical User 12months
(if Is 19 plus AND non ABQC) In the past 12 months, have you used cannabis for non-medical purposes in front of persons that are under 19 years old?
(if Is 18 plus AND AB) In the past 12 months, have you used cannabis for non-medical purposes in front of persons that are under 18 years old?
(if Is 21 plus AND QC) In the past 12 months, have you used cannabis for non-medical purposes in front of persons that are under 21 years old?
Q69 Show if Is 19 or older non ABQC OR 18 or older AB OR 21 or older QC AND 19 NonMedical User 12months
(if Is 19 plus AND non ABQC) In the past 12 months, have you shared cannabis for non-medical purposes with persons that are under 19 years old?
(if Is 18 plus AND AB) In the past 12 months, have you shared cannabis for non-medical purposes with persons that are under 18 years old?
(if Is 21 or older) In the past 12 months, have you shared cannabis for non-medical purposes with persons that are under 21 years old?
Q70 Show if Not legal age AND Q19 NonMedical user past 12 month
(if NonABQC Under 19) In the past 12 months, has someone 19 years of age or older shared cannabis for non-medical purposes with you?
(if AB Under 18) In the past 12 months, has someone 18 years of age or older shared cannabis for non-medical purposes with you?
(if QC Under 21) In the past 12 months, has someone 21 years of age or older shared cannabis for non-medical purposes with you?
Q71 Show if Is female AND 16 to 50 years
Have you given birth (including live and still births *?*) during the past 5 years?
*?* A still birth has a birth weight of 500 grams or more, or the duration of pregnancy is 20 weeks or longer.
Page BirthQuestions Show if Q16 Used nonmedical in lifetime
Q72 Show if Q71 Given birth past 5 years
After you learned that you were pregnant with your last child, did you use cannabis during the pregnancy?
Q73 Show if Q71 Given birth past 5 years
Was your last child breastfed or given your breast milk even for a short time?
Q74 Show if Q73 Breastfed
While you were breastfeeding your last child, did you use cannabis?
Section Medical_Use
Mcontinue
Page Medical_Intro Show if Q18 Medical user past 12 months
Mcontinue
You indicated that you have used cannabis for medical purposes. Would you be willing to complete a series of questions asking about your use of cannabis for medical purposes?
Please remember that you can stop the survey and return at a later time.
Section Medical_Use1 Show if Mcontinue Yes
MInt, M1, M2, M3, M4, M5, M6, M7a, M7b, M8, M9, M9a, M10a, M10b, M10c, M11a, M11b, M12, M12a, M12b, M13, M14, M15a, M15b, M15c, M15d, M15e, M15f, M15g, M15h, M15i, M16, M17a, M17b, M17c, M17d, M17e, M17f, M17g, M17h, M17i, M18, M19, M20a, M20b, M21, M22, M23a1, M23b1, M23a2, M23b2, M23a3, M23b3, M23a4, M23b4, M23a5, M23b5, M23a6, M23b6, M23a7, M23b7, M23a8, M23b8, M23a9, M23b9, M24, M25, M26, M26a, M26b, M27, M27a, M27b, M28
Page Medical_Usage
MInt
In this series of questions when we use the term cannabis, this includes marijuana, hashish, hash oil or any other products made from the cannabis plant, but not synthetic cannabinoids.
When we ask about use, this includes using cannabis in its dry form or when mixed or processed into another product such as an edible, concentrate, liquid, or other product for medical purposes.
By medical purposes we mean used to treat a disease/disorder or to improve symptoms associated with a disease/disorder.
M1 Show if Q18 Yes with medical document
Are you currently accessing cannabis for medical purposes through the Health Canada program?
M2 Show if Q18 Medical user past 12 months
Are you currently covered by insurance for cannabis for medical purposes?
M3 Show if Q18 Medical user past 12 months
In the past 12 months, how often did you typically use cannabis for medical purposes?
M4 Show if Q18 Medical user past 12 months
During the past 12 months, what type of effect did your cannabis use for medical purposes have on your:
Levels marked with * are randomized
M5 Show if Q18 Medical user past 12 months
For which of the following diseases/disorders do you use cannabis for medical purposes?
Select all that apply
M6 Show if Q18 Medical user past 12 months
For which of the following symptoms do you use cannabis for medical purposes?
Select all that apply
M7a Show if Q18 Medical user past 12 months
Has your use of cannabis for medical purposes allowed you to decrease your use of any other medications?
M7b Show if M7a Yes decreased other medications
Which medication(s) have you been able to reduce your use of since starting to use cannabis for medical purposes?
Select all that apply
M8 Show if Q18 Medical user past 12 months
Has your use of cannabis for medical purposes changed your consumption of the following substances?
M9 Show if Q18 Medical user past 12 months
In the past 12 months, where did you get the cannabis you used for medical purposes?
Select all that apply
M9a Show if M9 5 Health Canada licensed producer
Will you continue to directly access cannabis from a Health Canada Licensed Producer now that legal retail outlets and online sales are available for non-medical cannabis?
M10a Show if Q18 Medical user past 12 months
In the past 12 months, how often did you buy or receive any cannabis for medical purposes from a legal/licensed source?
M10b Show if M10a is 1 2 3 or 4
In the past 12 months, what were these sources?
Select all that apply
M10c Show if M10b 3 Someone shared with you
Did you pay the person(s) for the cannabis they shared with you?
M11a Show if Q18 is Medical user past 12 months AND M010a NOT always
In the past 12 months, how often did you buy or receive any cannabis for medical purposes from an illegal/unlicensed source?
M11b Show if M11a is 1 2 3 or 4
In the past 12 months, what were these sources?
Select all that apply
M12 Show if Q18 Medical user past 12 months
In the past 12 months, did you use the following method to consume cannabis for medical purposes?
Select all that apply
M12a Show if M12 Vaporized with a portable or nonportable device
What cannabis products did you use when vaporizing cannabis?
Select all that apply
M12b Show if M12 Vaporized with a portable vaping device
M13 Show if Q18 Medical user past 12 months
When choosing cannabis products for medical purposes, what levels of THC and CBD do you typically use?
M14 Show if Q18 Medical user past 12 months
In the past 12 months, have you used the following cannabis products for medical purposes?
Select all that apply
M15a Show if M14 1 Used Dried flower leaf past 12 months
When choosing cannabis products for medical purposes, what levels of THC and CBD do you typically use for:
Dried flower/leaf ?
Please make a selection in each of the CBD and THC sections.
THC Levels
CBD Levels
M15b Show if M14 2 Used Hashish kief past 12 months
When choosing cannabis products for medical purposes, what levels of THC and CBD do you typically use for:
Hashish/kief ?
Please make a selection in each of the CBD and THC sections.
THC Levels
CBD Levels
M15c Show if M14 3 Used Cannabis oil for oral past 12 months
When choosing cannabis products for medical purposes, what levels of THC and CBD do you typically use for:
Cannabis oil for oral use - e.g., in dropper/syringe, softgel/capsules, spray bottle ?
Please make a selection in each of the CBD and THC sections.
THC Levels
CBD Levels
M15d Show if M14 4 Used Cannabis vape pen past 12 months
When choosing cannabis products for medical purposes, what levels of THC and CBD do you typically use for:
Cannabis vape pens/cartridges ?
Please make a selection in each of the CBD and THC sections.
THC Levels
CBD Levels
M15e Show if M14 5 Used Cannabis concentrate past 12 months
When choosing cannabis products for medical purposes, what levels of THC and CBD do you typically use for:
Cannabis concentrate/extracts - e.g., shatter/wax/budder/butane honey oil ?
Please make a selection in each of the CBD and THC sections.
THC Levels
CBD Levels
M15f Show if M14 6 Used Cannabis edibles past 12 months
When choosing cannabis products for medical purposes, what levels of THC and CBD do you typically use for:
Cannabis edible food products - e.g., cookies, candy ?
Please make a selection in each of the CBD and THC sections.
THC Levels
CBD Levels
M15g Show if M14 7 Used Cannabis beverages past 12 months
When choosing cannabis products for medical purposes, what levels of THC and CBD do you typically use for:
Cannabis beverages - e.g., cola, tea, coffee ?
Please make a selection in each of the CBD and THC sections.
THC Levels
CBD Levels
M15h Show if M14 8 Used Topicals past 12 months
When choosing cannabis products for medical purposes, what levels of THC and CBD do you typically use for:
Topicals - e.g., lotion, ointment, creams applied to skin ?
Please make a selection in each of the CBD and THC sections.
THC Levels
CBD Levels
M15i Show if M14 9 Used Other past 12 months
When choosing cannabis products for medical purposes, what levels of THC and CBD do you typically use for:
Other: <<M14.specify(9)>> ?
Please make a selection in each of the CBD and THC sections.
THC Levels
CBD Levels
M16 Show if Q18 Medical user past 12 months
In the past 12 months, how often have you used the following cannabis products for medical purposes?
M17a Show if M14 1 Used Dried flower leaf past 12 months
On the days that you used:
Dried flower/leaf for medical purposes, how much did you typically use in a day?
Please select the amount closest to what you typically use
TREE QUESTION
M17b Show if M14 2 Used Hashish kief past 12 months
On the days that you used:
Hashish/kief for medical purposes, how much did you typically use in a day?
Please select the amount closest to what you typically use
TREE QUESTION
M17c Show if M14 3 Used Cannabis oil for oral past 12 months
On the days that you used:
Cannabis oil for oral use - e.g., in dropper/syringe, softgel/capsules, spray bottle for medical purposes, how much did you typically use in a day?
Please select the amount closest to what you typically use
TREE QUESTION
M17d Show if M14 4 Used Cannabis vape pen past 12 months
On the days that you used:
Cannabis vape pens/cartridges for medical purposes, how much did you typically use in a day?
Please select the amount closest to what you typically use
M17e Show if M14 5 Used Cannabis concentrate past 12 months
On the days that you used:
Cannabis concentrate/extracts - e.g., shatter/wax/budder/butane honey oil for medical purposes, how much did you typically use in a day?
Please select the amount closest to what you typically use
M17f Show if M14 6 Used Cannabis edibles past 12 months
On the days that you used:
Cannabis edible food products - e.g., cookies, candy for medical purposes, how much did you typically use in a day?
Please select the amount closest to what you typically use
TREE QUESTION
M17g Show if M14 7 Used Cannabis beverages past 12 months
On the days that you used:
Cannabis beverages - e.g., cola, tea, coffee for medical purposes, how much did you typically use in a day?
Please select the amount closest to what you typically use
TREE QUESTION
M17h Show if M14 8 Used Topicals past 12 months
On the days that you used:
Topicals - e.g., lotion, ointment, creams applied to skin for medical purposes, how much did you typically use in a day?
Please do not enter personally-identifying information.
M17i Show if M14 9 Used Other past 12 months
On the days that you used:
Other: <<M14.specify(9)>> for medical purposes, how much did you typically use in a day?
Please do not enter personally-identifying information.
M18 Show if Q18 Medical user past 12 months
How much do you typically spend on cannabis for medical purposes each month?
M19 Show if Q18 Medical user past 12 months
In the past 30 days, have you used cannabis for medical purposes (used to treat disease/disorder or improve symptoms)?
M20a Show if M19 Medical user past 30 days
In the past 30 days, how much did you spend on cannabis for medical purposes obtained from a legal source?
Minimum: 0.0, Maximum: 1000.0
Enter estimated dollar amount
M20b Show if M19 Medical user past 30 days
In the past 30 days, how much did you spend on cannabis for medical purposes obtained from an illegal source?
Minimum: 0.0, Maximum: 1000.0
Enter estimated dollar amount
M21 Show if M19 Medical user past 30 days
In the past 30 days, which forms of cannabis have you bought or received for medical purposes?
Select all that apply
M22 Show if M19 Medical user past 30 days
In the past 30 days, how often did you buy or receive cannabis for medical purposes?
M23a1 Show if M21 1 Obtained Dried flower leaf past 30 day
Typically, how much cannabis in the form:
Dried flower/leaf did you buy or receive each time for medical purposes?
Please select the amount closest to what you typically bought or received each time.
TREE QUESTION
M23b1 Show if M21 1 Obtained Dried flower leaf past 30 day
How much did you pay for this amount?
Minimum: 0.0, Maximum: 1000.0
Enter dollar amount
M23a2 Show if M21 2 Obtained Hashish kief past 30 days
Typically, how much cannabis in the form:
Hashish/kief did you buy or receive each time for medical purposes?
TREE QUESTION
M23b2 Show if M21 2 Obtained Hashish kief past 30 days
How much did you pay for this amount?
Minimum: 0.0, Maximum: 1000.0
Enter dollar amount
M23a3 Show if M21 3 Obtained Cannabis oil for oral past 30 days
Typically, how much cannabis in the form:
Cannabis oil for oral use - e.g., in dropper/syringe, softgel/capsules, spray bottle did you buy or receive each time for medical purposes?
TREE QUESTION
M23b3 Show if M21 3 Obtained Cannabis oil for oral past 30 days
How much did you pay for this amount?
Minimum: 0.0, Maximum: 1000.0
Enter dollar amount
M23a4 Show if M21 4 Obtained Cannabis vape pens past 3 days
Typically, how much cannabis in the form:
Cannabis vape pens/cartridges did you buy or receive each time for medical purposes?
M23b4 Show if M21 4 Obtained Cannabis vape pens past 3 days
How much did you pay for this amount?
Minimum: 0.0, Maximum: 1000.0
Enter dollar amount
M23a5 Show if M21 5 Obtained Cannabis concentrate past 30 days
Typically, how much cannabis in the form:
Cannabis concentrate/extracts - e.g., shatter/wax/budder/butane honey oil did you buy or receive each time for medical purposes?
TREE QUESTION
M23b5 Show if M21 5 Obtained Cannabis concentrate past 30 days
How much did you pay for this amount?
Minimum: 0.0, Maximum: 1000.0
Enter dollar amount
M23a6 Show if M21 6 Obtained Cannabis edibles past 30 days
Typically, how much cannabis in the form:
Cannabis edible food products - e.g., cookies, candy did you buy or receive each time for medical purposes?
TREE QUESTION
M23b6 Show if M21 6 Obtained Cannabis edibles past 30 days
How much did you pay for this amount?
Minimum: 0.0, Maximum: 1000.0
Enter dollar amount
M23a7 Show if M21 7 Obtained Cannabis beverages past 30 days
Typically, how much cannabis in the form:
Cannabis beverages - e.g., cola, tea, coffee did you buy or receive each time for medical purposes?
TREE QUESTION
M23b7 Show if M21 7 Obtained Cannabis beverages past 30 days
How much did you pay for this amount?
Minimum: 0.0, Maximum: 1000.0
Enter dollar amount
M23a8 Show if M21 8 Obtained Topicals past 30 days
Typically, how much cannabis in the form:
Topicals - e.g., lotion, ointment, creams applied to skin did you buy or receive each time for medical purposes?
Please do not enter personally-identifying information.
M23b8 Show if M21 8 Obtained Topicals past 30 days
How much did you pay for this amount?
Minimum: 0.0, Maximum: 1000.0
Enter dollar amount
M23a9 Show if M21 9 Obtained Other past 30 days
Typically, how much cannabis in the form:
Other: <<M21.specify(9)>> did you buy or receive each time for medical purposes?
Please do not enter personally-identifying information.
M23b9 Show if M21 9 Obtained Other past 30 days
How much did you pay for this amount?
Minimum: 0.0, Maximum: 1000.0
Enter dollar amount
M24 Show if Q18 Medical user past 12 months
In your opinion, does using cannabis for medical purposes impair one's ability to drive or operate a motor vehicle?
Don't know/Not sure
M25 Show if Q18 Medical user past 12 months
As far as you know, when is it safe for someone to drive a motor vehicle after using cannabis for medical purposes?
M26 Show if Q18 Medical user past 12 months
Have you driven a motor vehicle (e.g., car, snowmobile, motor boat or all-terrain vehicle (ATV)) within 2 hours of smoking or vaporizing cannabis or a cannabis product for medical purposes?
M26a Show if M26 Yes driven within 2hrs of smoking vaping
When did this last happen?
M26b Show if M26 Yes AND M26a within past 30 days
What type of cannabis product was it?
M27 Show if Q18 Medical user past 12 months
Have you driven a motor vehicle (e.g., car, snowmobile, motor boat or all-terrain vehicle (ATV)) within 4 hours of ingesting a cannabis product (e.g., cannabis food/beverages, capsules) for medical purposes?
M27a Show if M27 Yes driven within 4hrs of eating
When did this last happen?
M27b Show if M27 Yes AND M27a within past 30 days
What type of cannabis product was it?
M28 Show if M26 Yes driven 2hrs smoking vaping OR M27 Yes driven 4hrs eating
Why did you drive a motor vehicle after using cannabis for medical purposes?
Select all that apply
Section Pretest
P1, P2
Page PretestQs
P1
We would now like your opinion on this survey itself.
Overall, how would you rate the extent to which the questions in this survey were easy to understand? Please use a scale from 0 to 10 where 0 means very difficult, and 10 means very easy.
P2 Show if P1 Less than 8
Please tell us why you gave this rating to the survey. What specific words or questions did you find difficult to understand?
Section Ending
F1, End1
Page Ends
F1
Finally, would you be willing to participate in this study again in the future?
End1
You have now completed the survey
Thank you very much for participating in this survey.
Status Code: -1
Footnotes